mFluiDx
mFluiDx is developing a point-of-care molecular test called the “SIMPLE CHIP” that aims to provide PCR-equivalent results at a cost comparable to rapid antigen tests, enabling rapid, decentralized, on-site screening for multiple pathogens. The company is a UC Berkeley spin-out and is supported by various incubators and grants, with a mission to improve infectious disease diagnostics.
Industries
biotechnology
health-care
health-diagnostics
Nr. of Employees
small (1-50)
Products
Prototype disposable microfluidic diagnostic cartridge and reader
Prototype point-of-care diagnostic system composed of a disposable microfluidic cartridge and a reader instrument enabling automated, multiplexed nucleic acid testing with rapid turnaround.
Prototype disposable microfluidic diagnostic cartridge and reader
Prototype point-of-care diagnostic system composed of a disposable microfluidic cartridge and a reader instrument enabling automated, multiplexed nucleic acid testing with rapid turnaround.
Services
Development of point-of-care molecular diagnostic systems
R&D service to develop integrated diagnostic prototypes consisting of disposable microfluidic cartridges and reader instruments for decentralized testing.
Development of point-of-care molecular diagnostic systems
R&D service to develop integrated diagnostic prototypes consisting of disposable microfluidic cartridges and reader instruments for decentralized testing.
Expertise Areas
- Point-of-care molecular diagnostics development
- Microfluidic cartridge design and low-cost consumable manufacturing
- Multiplexed nucleic acid testing
- Sample-to-answer automation
Key Technologies
- Microfluidics
- Isothermal nucleic acid amplification
- Multiplexed nucleic acid detection
- Disposable cartridge + reader instrument architecture